Carola Berking

A multicenter DeCOG study on predictors of vemurafenib therapy outcome in melanoma: pretreatment impacts survival.

J. Utikal, C. Berking, D. Schadendorf, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Radiosensitization by BRAF inhibitor therapy-mechanism and frequency of toxicity in melanoma patients.

C. Berking, D. Schadendorf, H. Eich, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Treatment management for BRAF-mutant melanoma patients with tumor recurrence on adjuvant therapy: a multicenter study from the prospective skin cancer registry ADOREG

M. Weichenthal, A. Hauschild, S. Haferkamp, 2023, Journal for ImmunoTherapy of Cancer.

5¢-triphosphate-sirna: Turning Gene Silencing and Rig-i Activation against Melanoma

Svetlana Shulga Morskaya, M. Neuenhahn, J. Ruland, 2022 .